Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you manage pleomorphic adenoma of minor salivary glands involving hypopharynx/larynx with positive surgical margin?
Would you offer adjuvant radiation? Dose/volume in postop setting?
Answer from: Radiation Oncologist at Academic Institution
Postop RT with carcinoma doses.
Sign in or Register to read more
16851
Related Questions
In oral cavity cancers, how does WPOI (worse pattern of invasion) influence your decision to offer adjuvant therapy?
How would you simulate and ensure set-up reproducibility for a patient with head and neck cancer and severe claustrophobia and unable to tolerate a thermoplastic mask?
When do you recommend adjuvant radiotherapy for a resected oncocytic carcinoma of the submandibular gland?
What are the indications, doses, and volumes for postoperative radiation for parathyroid carcinomas?
Does the extent of ENE affect your recommendation for concurrent chemotherapy in HPV+ OPSCC patients planned for adjuvant RT?
For a small (<5 mm) hard/soft palate junctional primary with DOI <2 mm status post limited excision with negative but close deep margin, how would you approach neck management in the adjuvant RT setting?
How do you balance the need for wound healing and time to treatment initiation in head and neck cancer patients who require a second operation?
Per the latest ASCO and ESMO guidelines, which stage II NPC patients would you omit concurrent cisplatin?
In light of de-escalation data, for patients undergoing standard dose radiation for favorable HPV + oropharynx cancer, do you accept lower coverage of the low-dose RT field to better spare OARS?
Are you treating with the superoxide dismutase mimetic Avasopasem (GC4419) for patients receiving chemoradiation for head & neck cancers?